The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Larimar Therapeutics Inc’s current trading price is -48.17% away from its 52-week high, while its distance from the 52-week low is 225.23%. The stock’s price range for this period has been between $2.18 and $13.68 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.0 million for the day, a number notably higher than the average daily volume of 0.57 million over the last three months.
The market performance of Larimar Therapeutics Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $13.68 on 02/15/24, while the lowest value for the same duration was $2.18 on 11/10/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Larimar Therapeutics Inc (LRMR) has experienced a quarterly decline of -22.56% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 452.41M and boasts a workforce of 42 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.98, with a change in price of -0.78. Similarly, Larimar Therapeutics Inc recorded 621,536 in trading volume during the last 100 days, posting a change of -9.91%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for LRMR stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.02.
LRMR Stock Stochastic Average
As of today, Larimar Therapeutics Inc’s raw stochastic average for the last 50 days stands at 32.80%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 52.12%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 33.17% and 23.34%, respectively.
LRMR Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The index has shown a price gain of 55.82% this year. Over the last six months, there has been a weaker performance of 0.71%. The price of LRMR leaped by -5.97% during the last 30 days period. For the last 5-days stocks have improved 13.08%.
